Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Kenneth Raymond"'
Autor:
Jiezhong Chen, Kenneth Raymond
Publikováno v:
Vascular Health and Risk Management, Vol Volume 4, Pp 1265-1272 (2008)
Jiezhong Chen1,3, Kenneth Raymond21John Curtin School of Medical Research, Australian National University, Acton, ACT, Australia; 2School of Pharmacy and Applied Science, Faculty of Science, Technology and Engineering, LaTrobe University, Bendigo, Vi
Externí odkaz:
https://doaj.org/article/4756249cb28144bdb3cc19bf7a93310d
Autor:
Daniels, Kenneth Raymond
Publikováno v:
In Journal of Obstetrics and Gynaecology Canada January 2002 24(1):17-21
Utilizing community pharmacy dispensing records to disclose errors in hospital admission drug charts
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 50:639-646
Objective: To identify and resolve discrepancies in admission medication histories, utilizing community pharmacy dispensing data, in newly hospitalized patients and investigate the relationship between unresolved discrepancies and length of hospital
Publikováno v:
Journal for Nurses in Staff Development (JNSD). 23:173-179
This qualitative pilot study explored nurses' attitudes toward their role in patients' discharge medication education and collaboration with pharmacists. Purposive sampling was used, and data were collected by a focus group interview. The findings gi
Autor:
Kenneth Raymond, Jiezhong Chen
Publikováno v:
International Journal of Gastrointestinal Cancer. 37:79-83
Hepatoma is caused by many factors including alcohol, chemicals, viral infection, and chronic inflammation. Cytochrome P450 polymorphism plays an important role in its pathogenesis. CYP2D6, CYP2E1, and CYP1A1 have been identified to be related with h
Autor:
Kam Wai Clifford Chan, Gabriel W.K. Yip, Kenneth Raymond, John E. Sanderson, Kam S. Woo, Leata Y.C. Yeung, Skiva Chan
Publikováno v:
Journal of the American College of Cardiology. 34:1522-1528
OBJECTIVES This study was performed to compare the long-term clinical efficacy of treatment with metoprolol versus carvedilol in patients with chronic heart failure. BACKGROUND Beta-adrenergic blockade is of proven value in chronic heart failure. Met
Autor:
Wilson W.M. Chan, Kam S. Woo, Leata Yeung, Kam Wai Clifford Chan, John E. Sanderson, Kenneth Raymond, C.M. Yu, Skiva Chan
Publikováno v:
Heart. 79:86-92
Objective—To determine whether a third generation vasodilating β blocker (celiprolol) has long term clinical advantages over metoprolol in patients with chronic heart failure. Design—A double blind placebo controlled randomised trial. Setting—
Autor:
Kenneth Raymond, Jiezhong Chen
Publikováno v:
The Lancet. 367:454-456
Publikováno v:
American Journal of Therapeutics. 4:92-98
Two major concerns in therapeutics are the efficacy (E) and adverse effects (Ae) exhibited by a pharmacological agent. Although these elements are studied routinely in both animals and humans during the drug development processes, the data are usuall